Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution

被引：17
|
作者：
Yanaka, Kenichi [1 ]
Guillien, Alicia [2 ]
Soumagne, Thibaud [3 ]
Benet, Justin [4 ]
Piliero, Nicolas [1 ]
Picard, Francois [5 ]
Pison, Christophe [4 ]
Sitbon, Olivier [6 ,7 ,8 ]
Bouvaist, Helene [1 ]
Degano, Bruno [9 ]
机构：
[1] Grenoble Alpes Univ Hosp, Dept Cardiol, Grenoble, France
[2] Univ Grenoble Alpes, Environm Epidemiol Reprod & Resp Hlth, CNRS, INSERM,Inst Adv Biosci IAB,U1209,Joint Res Ctr, Grenoble, France
[3] Univ Hosp, Dept Intens Care Med, Besancon, France
[4] Univ Hosp Grenoble Alpes, Dept Resp Med, Grenoble, France
[5] Dept Cardiol, Pessac, France
[6] Univ Paris Saclay, Le Kremlin Bicetre, France
[7] Bicetre Hosp, AP HP, Dept Resp Med, Le Kremlin Bicetre, France
[8] INSERM, UMR S999, Le Plessis Robinson, France
[9] Univ Grenoble Alpes, INSERM, HP2 Lab, U1042, Grenoble, France
来源：
EUROPEAN RESPIRATORY JOURNAL | 2020年 / 55卷 / 06期
关键词：
PROSTACYCLIN; THERAPY;
D O I：
10.1183/13993003.02418-2019
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Transitioning intravenous epoprostenol to oral selexipag in idiopathic pulmonary arterial hypertension: a case report
    Alexandre, Andre
    Furtado, Ines
    Carvalho, Luisa
    Goncalves, Fabienne
    Melo, Alzira
    Alves, Joana
    Santos, Mario
    Reis, Abilio
    [J]. ESC HEART FAILURE, 2023, 10 (04): : 2722 - 2727
  • [2] A SUCCESSFUL RAPID TRANSITION FROM EPOPROSTENOL TO SELEXIPAG MONOTHERAPY IN A PATIENT WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION
    Kim, Jeremy
    Markin, Catherine
    Diwan, Johnell
    [J]. CHEST, 2018, 154 (04) : 1002A - 1003A
  • [3] SUCCESSFUL TRANSITION OF IV EPOPROSTENOL TO ORAL SELEXIPAG IN SEVERE PULMONARY ARTERIAL HYPERTENSION
    Litwak, Jane
    Sargent, Therese
    Maga, Alexandra
    Hall, Scott
    [J]. CRITICAL CARE MEDICINE, 2020, 48
  • [4] Single Center Experience In Transitioning Pulmonary Arterial Hypertension Patients From Intravenous Epoprostenol To Oral Selexipag
    Safdar, Z.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension
    Koo, Rachel
    Lo, Jennifer
    Bock, Matthew J.
    [J]. CARDIOLOGY IN THE YOUNG, 2019, 29 (06) : 849 - 851
  • [6] Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil
    Ivy, D. Dunbar
    Claussen, Lori
    Doran, Aimee
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 696 - 698
  • [7] Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
    Gomberg-Maitland, M
    Tapson, VF
    Benza, RL
    McLaughlin, VV
    Krichman, A
    Widlitz, AC
    Barst, RJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1586 - 1589
  • [8] Successful Transition from Oral Selexipag to Intravenous Epoprostenol
    Morales-Estrella, J. L.
    Chen, A.
    Heresi, G. A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [9] THERMOSTABLE INTRAVENOUS EPOPROSTENOL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION - A TRANSITION STUDY
    MacLellan, A.
    Carson, K.
    Brewis, M.
    Johnson, M.
    McGettrick, M.
    McCaughey, P.
    Crozier, A.
    Thomson, R.
    Church, C.
    [J]. THORAX, 2019, 74 : A152 - A153
  • [10] Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus
    Saiki, Chihiro
    Kashiwado, Yusuke
    Yokoyama, Taku
    Ayano, Masahiro
    Imabayashi, Keisuke
    Kawano, Shotaro
    Higashioka, Kazuhiko
    Kimoto, Yasutaka
    Fukata, Mitsuhiro
    Mitoma, Hiroki
    Ono, Nobuyuki
    Arinobu, Yojiro
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    [J]. MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (02) : 183 - 188
12345